NCT02943356View on ClinicalTrials.gov

Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction

PHASE4UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Erectile DysfunctionAndropause
Interventions
DRUG

Tadalafil

Patients will be treated with Tadalafil for 8 weeks

Trial Locations (1)

Unknown

RECRUITING

Uijeongbu St.Mary's Hospital, Gyeonggi-do

Sponsors
All Listed Sponsors
collaborator

Hanmi Pharmaceutical Company Limited

INDUSTRY

lead

The Catholic University of Korea

OTHER

NCT02943356 - Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction | Biotech Hunter | Biotech Hunter